Solvency 2 (Group Supervision) (Amendment) Regulations 2021

Lord Tunnicliffe Excerpts

Tuesday 7th December 2021 Grand Committee

[Viscount Younger of Leckie (Con)]

My Lords, I beg to move that the Committee considers the Solvency 2 (Group Supervision) (Amendment) Regulations 2021. This instrument is being made to address deficiencies in retained EU law relating to the supervision of UK insurance groups under the insurance prudential regime known as Solvency II.

The onshoring of large amounts of EU legislation into domestic law was a vast, complex and time-pressured process. I hardly need remind your Lordships that over 60 statutory instruments were passed; one of these related to Solvency II. This was not an easy feat, since Solvency II is a particularly technical and complex regime, so it is unsurprising that, among the sheer volume of complicated work, there was an oversight that means a technical fix now needs to be made. By this instrument, we are taking action now to ensure that this oversight is addressed well before any potential issues materialise from 1 April 2022.

I will explain what the instrument does and why it prevents a cliff edge on 1 April 2022. The UK Government have made equivalence decisions which assess that the insurance group supervision regime in another country, a so-called third country, is equivalent to the UK. To date, Bermuda, Switzerland and the EEA countries have been determined to be equivalent to the UK for the purpose of insurance group supervision. This instrument will ensure that the UK Government’s equivalence decisions achieve in full the objective of avoiding unnecessary duplication of supervisory work.

I will give a practical example of the type of duplication this instrument seeks to remove. Where a waiver is granted by the PRA, a UK subgroup that is supervised at ultimate parent level by an equivalent supervisor will not need to submit quarterly and annual group reporting templates to the PRA, or prepare an annual report known as the “own risk and solvency assessment”, or publish an annual group report known as the “solvency and financial condition report”.

Using a typical large insurer as an example, I will illustrate how extensive these submissions are and the time and cost savings this instrument may achieve. The solvency financial and condition report of a large insurer can be over 100 pages long. It has qualitative and quantitative materials and sets out aspects of the insurer’s business and performance, system of governance, risk profile, valuation methods used for solvency purposes, and capital management practices. The production of such a report requires analysis and co-ordination by experts in multiple disciplines such as actuarial, finance, accounting, internal audit, IT and risk management, not to mention board and senior management input and review. I stress that this is only one example of the supervisory compliance materials that we are seeking to remove.

The costs of duplication would vary from firm to firm but comprise initial one-off costs as well as ongoing costs as high as £500,000 per annum. Without this instrument, the UK subgroup must duplicate these materials at the UK subgroup level, when its parent already produces equivalent materials for submission to the third country supervisory authorities. The advantages are: reduced regulatory compliance cost for the insurance groups; reduced supervisory cost for the PRA; and reduced need for co-ordination between third country supervisory authorities and the PRA where duplicative materials are being reviewed.

The statutory instrument affects UK insurance groups whose parent companies are domiciled in equivalent third countries. Such insurance groups are supervised at two levels: the UK insurance group level is supervised by the PRA, and the ultimate parent group level, the so-called worldwide group, is supervised by the supervisory authority in the relevant third country. Currently, a total of 11 insurance groups are expected to benefit from this instrument. Of the 11, five have parent companies in EEA countries and six have parent groups in Switzerland or Bermuda. Examples of such groups include AXA, Allianz, Ageas and Hiscox. To take Hiscox as an example, it has headquarters in Bermuda and is listed on the London Stock Exchange. With this instrument, the PRA may rely on the supervisory authority in Bermuda to conduct group supervision of the entire group, of which the UK subgroup of Hiscox is a subset.

I assure noble Lords that this is not a relaxation of prudential standards; the proposed changes aim to provide full effect to the Treasury’s equivalence determinations. Although the UK group supervisory requirements are waived, the main safeguard for UK policyholders remains. This main safeguard is the continued supervision of solo UK entities belonging to these UK subgroups. This supervisory work cannot be waived.

In addition to this main safeguard, UK policyholders are further protected via the requirement for UK subgroups to submit supervisory materials to the PRA, where necessary, beyond the reliance that the PRA may place on equivalent supervisors. For example, UK subgroups are still expected to submit the annual consolidated statutory accounts to the PRA. They also need to notify the PRA prior to taking certain actions, such as the acquisition or disposal of subsidiaries and changes to existing borrowing facilities. This ensures that the PRA is still able to protect UK policyholders while supervising the solo UK entities belonging to such groups in a proportionate manner.

The instrument enables the PRA, when certain conditions are met, to defer to third country supervisory authorities, if the UK has determined that the third countries are equivalent for the purposes of insurance group supervision. The conditions are: where compliance by firms would be overly burdensome; and where waiving the requirements does not adversely impact the PRA’s advancements of its objectives. In this circumstance, the PRA may disapply or modify regulatory requirements, which amounts to issuing waivers to UK insurance groups. In effect, the waivers exempt these UK insurance groups from demonstrating to the PRA compliance with Solvency II group supervision requirements at the UK subgroup level. This is in recognition that compliance at the UK subgroup level has already been supervised by virtue of being a subset of the ultimate group that is supervised by the equivalent third countries.

Pre-EU exit, the European Insurance and Occupational Pensions Authority issued guidelines to allow EEA supervisors to issue such waivers. It was under such guidelines that the PRA was able to issue waivers to affected UK insurance groups pre-EU exit. However, these guidelines ceased to have effect in the UK following EU exit. Consequently, existing waivers are due to expire on 31 March 2022, and this statutory instrument confers on the PRA the power to issue new waivers.

On 2 December 2021, in its 22nd report, the Secondary Legislation Scrutiny Committee listed this instrument as an “instrument of interest”. The report noted

“the absence of a level playing field”

in that

“while the UK has granted equivalence to the EU in relation to the supervision of insurance groups, the EU has not reciprocated.”

While that is true, I urge the Committee not to conflate two separate matters. Equivalence determinations are made by the UK and the EU unilaterally. One decision is within the power of the UK Government, and another is beyond the power of the UK Government. Where the UK Government have unilaterally determined equivalence, we have a duty to ensure that our decisions are meaningful and achieve their objectives in full. This instrument ensures that we do not undermine our own equivalence decisions with deficiencies in our domestic law. So, rejecting this instrument does not increase the probability of the EU reciprocating equivalence decisions. Conversely, it would penalise UK insurance groups and our regulator by increasing regulatory compliance and supervisory cost.

After that rather full explanation, I conclude by saying that the Treasury has worked closely with the PRA in drafting this instrument. It has also engaged with the UK insurance industry through its industry body, the Association of British Insurers—ABI. The ABI has informed the Treasury that the industry welcomes this statutory instrument and has no concerns with it. I beg to move.

[Lord Tunnicliffe (Lab)]

My Lords, I appreciate the Minister’s introduction of this second statutory instrument. It is a somewhat simpler SI than the previous one but will nevertheless be important in the day-to-day regulation and operation of insurance groups.

As the Minister outlined, the regulations make a series of changes to ease the regulatory burden on the Prudential Regulation Authority—PRA. This is intended to save costs for both the regulator and insurance groups themselves. Under the new arrangements, the PRA would be able to defer to the decisions of the regulatory body or bodies of relevant third countries in certain circumstances. In practice, this is likely to be EU bodies, although the provisions cover non-EU third countries too. Where third countries have been deemed a regulatory equivalent to the UK and happen to host the parent company of a PRA-regulated insurance group, the PRA may choose to defer to relevant decisions made in the other jurisdiction, avoiding unnecessary duplication of work and costs.